11.10.25 -- Manager Alignment And Integration: Best Practices When Working With A CDMO

Ensure a smooth and successful technology transfer by implementing strategic planning, communication, robust training, and clear agreements to optimize your biopharmaceutical manufacturing process.

Learn how next-generation workflows are being developed to streamline iPSC manufacturing, enhance differentiation strategies, and overcome the hurdles of scalability and consistency.

This study evaluates filter trains from four vendors, aiming to enhance titer recovery, HCP removal, DNA breakthrough, turbidity reduction, and throughput in gene therapy manufacturing.

Discover how one family defied the odds — bringing a lifesaving gene therapy from idea to treatment in just 14 months after a devastating rare disease diagnosis.

Assimilate how to effectively navigate the transition to GMP, ensuring your project meets stringent requirements while streamlining development and minimizing risk.

In a recent webinar, Novartis Contract Manufacturing experts explored innovations in viral vector manufacturing and addressed production challenges and quality control strategies.

Uncover guiding principles to ensure that your CGT supply chain is future-proof and learn how an agile, flexible approach can help advance your project with reduced costs and delays.

Unlock the potential of AAV manufacturing by leveraging data-driven insights and the advanced Pro10™ platform to optimize processes, enhance productivity, and drive innovation in cell and gene therapy.

Don’t miss this compelling interview with Boro Dropulić, CEO of Caring Cross, on how the cell and gene therapy sector can turn scientific breakthroughs into global health solutions.

Review the potential of AAV-mediated gene therapy as a platform approach to treat multiple genetic neurological diseases, and explore suggestions to streamline translational studies and reduce costs.

Through a side-by-side evaluation, we present a comprehensive analysis of various published and newly developed dsDNA conversion processes tested using the same sequencing chemistry.

This study highlights how we overcame developmental challenges by employing a customized approach that leveraged scientific expertise, strategic collaboration, and effective governance.

Gain insights into how standardized quality controls, robust analytics, and streamlined processes can improve efficiency, reliability, and scalability across the development lifecycle.